Department of Digestive Surgery, Hospital of Avranches-Granville, Avranches, France; UMR INSERM 1086 'ANTICIPE', Centre François Baclesse, Caen, France.
Registre des cancers digestifs de Bourgogne, University Hospital of Dijon, Dijon, France; INSERM UMR 1231, University of Burgundy, Dijon, France.
Eur J Surg Oncol. 2023 Aug;49(8):1450-1456. doi: 10.1016/j.ejso.2023.03.228. Epub 2023 Apr 8.
Resection is the cornerstone of curative management for pancreatic ductal adenocarcinoma (PDAC). Hospital surgical volume influence post-operative mortality. Few is known about impact on survival.
Population included 763 patients resected for PDAC within the 4 French digestive tumor registries between 2000 and 2014. Spline method was used to determine annual surgical volume thresholds influencing survival. A multilevel survival regression model was used to study center effect.
Population was divided into three groups: low-volume (LVC) (<41 hepatobiliary/pancreatic procedures/year), medium-volume (MVC) (41-233) and high-volume centers (HVC) (>233). Patients in LVC were older (p = 0.02), had a lower rate of disease-free margins (76.7% vs. 77.2% and 69.5%, p = 0.028) and a higher post-operative mortality than in MVC and HVC (12.5% and 7.5% vs. 2.2%; p = 0.004). Median survival was higher in HVC than in other centers (25 vs. 15.2 months, p < 0.0001). Survival variance attributable to center effect accounted for 3.7% of total variance. In multilevel survival analysis, surgical volume explained the inter-hospital survival heterogeneity (non-significant variance after adding the volume to the model p = 0.3). Patients resected in HVC had a better survival than in LVC (HR 0.64 [0.50-0.82], p < 0.0001). There was no difference between MVC and HVC.
Regarding center effect, individual characteristics had little impact on survival variability across hospitals. Hospital volume was a major contributor to the center effect. Given the difficulty of centralizing pancreatic surgery, it would be wise to determine which factors would indicate management in a HVC.
切除术是治疗胰腺导管腺癌(PDAC)的基石。医院手术量影响术后死亡率。但关于对生存率的影响知之甚少。
本研究纳入了 2000 年至 2014 年期间在法国 4 个消化肿瘤登记处接受 PDAC 切除术的 763 名患者。采用样条法确定影响生存的年度手术量阈值。使用多级生存回归模型研究中心效应。
人群分为三组:低容量(LVC)组(<41 例肝胆胰手术/年)、中容量(MVC)组(41-233 例)和高容量中心(HVC)组(>233 例)。LVC 组患者年龄较大(p=0.02),无疾病边缘的比例较低(76.7%比 77.2%和 69.5%,p=0.028),术后死亡率高于 MVC 和 HVC 组(12.5%和 7.5%比 2.2%;p=0.004)。HVC 组的中位生存时间高于其他中心(25 比 15.2 个月,p<0.0001)。中心效应归因于生存方差的 3.7%。在多水平生存分析中,手术量解释了医院间生存的异质性(在向模型中添加体积后,非显著方差 p=0.3)。与 LVC 相比,HVC 切除的患者生存更好(HR 0.64 [0.50-0.82],p<0.0001)。MVC 和 HVC 之间没有差异。
关于中心效应,个体特征对医院间生存变异的影响很小。医院容量是中心效应的主要因素。鉴于胰腺手术集中化的困难,明智的做法是确定哪些因素表明在 HVC 中进行管理。